Ezetimibe: A First-in-Class, Novel Cholesterol Absorption Inhibitor
Author:
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1527-3466.2003.tb00123.x/fullpdf
Reference69 articles.
1. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: A prospective, randomized, double-blind trial;Ballantyne;Circulation,2003
2. Ezetimibe does not affect the pharmacokinetics or pharmacodynamics of warfarin [abstract];Bauer;Clin Pharmacol Ther,2001
3. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two Phase II studies;Bays;Clin Ther,2001
4. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters;Berge;Science,2000
5. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia;Davidson;J Am Coll Cardiol,2002
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recommending Drug Combinations Using Reinforcement Learning targeting Genes/proteins associated with Heterozygous Familial Hypercholesterolemia: A comprehensive Systematic Review and Net-work Meta-analysis;2023-02-16
2. Investigation of the discriminatory ability of analytes for the bioequivalence assessment of ezetimibe: Parent drug, metabolite, total form, and combination of parent drug and total form;European Journal of Pharmaceutical Sciences;2022-07
3. Inhibition of Niemann-Pick C1-like protein 1 by ezetimibe reduces uptake of deuterium-labeled vitamin D in mice;The Journal of Steroid Biochemistry and Molecular Biology;2020-03
4. Solidified nanostructured lipid carrier (S-NLC) for enhancing the oral bioavailability of ezetimibe;Journal of Drug Delivery Science and Technology;2019-10
5. Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias;Current Pharmaceutical Design;2019-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3